Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Green Flag and 1 Red Flag for Novo Nordisk

TheMotleyFool

0 0

1 Green Flag and 1 Red Flag for Novo Nordisk: https://g.foolcdn.com/editorial/images/751289/physician-talking-to-patient.jpg

It's hard to overstate how well Novo Nordisk (NYSE: NVO) has performed over the past year. The Denmark-based company has even been credited for helping lift the economy of its country. It has routinely delivered excellent financial results and solid clinical progress, things investors interested in drugmakers want to see.

However, following its performance in the past 12 months, some might think it's too late to invest in Novo Nordisk. Is that the case? Let's consider one argument on each side.